Curis
CRIS
#11244
Rank
NZ$2.58 M
Marketcap
NZ$1.07
Share price
9.39%
Change (1 day)
-58.92%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2026 (TTM): -NZ$15.06 Million

According to Curis's latest financial reports the company's current earnings are NZ$4.31 Million. In 2025 the company made an earning of -NZ$9.59 Million, an increase over its 2024 earnings that were of -NZ$75.95 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$15.06 Million57.07%
2025 -NZ$9.59 Million-87.38%
2024 -NZ$75.95 Million-5.77%
2023 -NZ$80.61 Million-13.1%
2022 -NZ$92.75 Million27.52%
2021 -NZ$72.74 Million65.09%
2020 -NZ$44.06 Million-9.1%
2019 -NZ$48.47 Million-4.73%
2018 -NZ$50.88 Million-41.95%
2017 -NZ$87.63 Million-14.37%
2016 -NZ$0.11 Billion3.55%
2015 -NZ$98.83 Million271.52%
2014 -NZ$26.6 Million76.64%
2013 -NZ$15.06 Million
2011 -NZ$12.79 Million27.76%
2010 -NZ$10.02 Million-43.87%
2009 -NZ$17.84 Million-23.44%
2008 -NZ$23.3 Million56.66%
2007 -NZ$14.87 Million-16.71%
2006 -NZ$17.86 Million-36.92%
2005 -NZ$28.31 Million156.25%
2004 -NZ$11.05 Million-37.24%
2003 -NZ$17.6 Million-93.34%
2002 -NZ$0.27 Billion86.79%
2001 -NZ$0.15 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$12.26 B-81,859.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$21.14 B-141,080.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-NZ$0.11 Billion 632.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$1.83 B-12,356.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.58 Billion 3,756.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-NZ$39.53 Million 163.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-NZ$0.17 Billion 1,025.71%๐Ÿ‡บ๐Ÿ‡ธ USA